Shape the right strategy very early and define the make or break elements to ensure behavioural change.
AXXELIS brings 53 person-years of global and local launch experience across twelve principle disease areas including endocrinology (including diabetes), immunology, ophthalmology, dermatology, cardiovascular, neurology, psychiatry, haematology, rheumatology, oncology, urology, infectious diseases.
We have experience in new products, devices, new indications and extensions across large and mid-sized pharmaceutical companies as well as start-ups.